Skip to main content
The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 10, 2010

Articles

Targeted Enzyme Prodrug Therapies
pp. 887-904(18)
Authors: Schellmann, N.; Deckert, P.M.; Bachran, D.; Fuchs, H.; Bachran, C.

Favourites:
ADD
Favourites:
ADD

New Strategies and Patent Therapeutics in EBV-Associated Diseases
pp. 914-927(14)
Authors: Villegas, E.; Santiago, O.; Sorlozano, A.; Gutierrez, J.

Favourites:
ADD

Mechanisms of Resistance to Antimicrobial Drugs in Pathogenic Gram-Positive Cocci
pp. 928-937(10)
Authors: Mlynarczyk, B.; Mlynarczyk, A.; Kmera-Muszynska, M.; Majewski, S.; Mlynarczyk, G.

Favourites:
ADD
Favourites:
ADD

Alkaloids from Cyanobacteria with Diverse Powerful Bioactivities
pp. 946-955(10)
Authors: Vasas, G.; Borbely, G.; Nanasi, P.; Nanasi, P.P.

Favourites:
ADD

Target Therapies in Systemic Lupus Erythematosus: Current State of the Art
pp. 956-965(10)
Authors: Wiesik-Szewczyk, E.; Lacki, J.K.; Feleszko, W.; Olesinska, M.

Favourites:
ADD

Cosalane and its Analogues: A Unique Class of Anti-HIV Agents
pp. 966-976(11)
Authors: Zhan, Peng; Li, Zhenyu; Liu, Xinyong

Favourites:
ADD

Spirobisnaphthalenes from Fungi and their Biological Activities
pp. 977-989(13)
Authors: Zhou, L.; Zhao, J.; Shan, T.; Cai, X.; Peng, Y.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content